ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease (ALZ)

This study is enrolling participants by invitation only.
Information provided by University of Wisconsin, Madison

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
Official Title  fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
Brief Summary

The purpose of this study is to investigate the organization of memory and develop future methods for early detection of AD. Using functional magnetic resonance imaging (fMRI), we examine the responsiveness of the brain to memory tasks, specifically focusing on regions of the brain (the mesial temporal lobe and posterior cingulate) that are known to be involved in early stages of Alzheimer's disease (AD). Of interest are differences in brain activation between people with and without a family history of AD and other risk factors.

Detailed Description
Study Phase
Study Type  Observational
Study Design  Case Control, Prospective
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Magnetic Resonance Imaging
Alzheimer's Disease
Dementia
Adult Children
Risk
Intervention 
MEDLINE PMIDs 17445294,   16738250,   16412236,   16321166,   16102979
Links Website for the Sterling Johnson Imaging Lab This link exits the ClinicalTrials.gov site
Website for the Wisconsin Comprehensive Memory Program This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Enrolling by invitation
Enrollment  390
Start Date  January 2003
Completion Date July 2009
Eligibility Criteria 

Inclusion Criteria:

  • MCI Group: Diagnosis of mild cognitive impairment
  • AD Family History Group: Confirmed family history of Alzheimer's and concurrent enrollment in the Wisconsin Registry for Alzheimer's Prevention (WRAP)
  • Control Groups: Cognitively healthy and both parents survived past age 70 with no memory problems

Exclusion Criteria:

  • Claustrophobia
  • Metallic or electronic implants or devices that are not MRI-safe
Gender Both
Ages 40 Years to 85 Years
Accepts Healthy Volunteers Yes
Contacts ††
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00478491
Organization ID 2002-515
Secondary IDs †† NIH RO1 AG021155A
Study Sponsor  University of Wisconsin, Madison
Collaborators †† National Institutes of Health (NIH)
National Institute on Aging (NIA)
Investigators 
Principal Investigator:     Sterling C Johnson, PhD     University of Wisconsin/VA GRECC    
Information Provided By University of Wisconsin, Madison
Verification Date December 2007
First Received Date  May 22, 2007
Last Updated Date December 19, 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers